期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

慢性心力衰竭治疗新进展 被引量：6

原文传递
导出
摘要 慢性心力衰竭（简称心衰）作为一种进展性临床综合征，通常是指心肌收缩功能明显减退，使心排血量降低，伴有左心室舒张末压增高，临床上引起肺淤血和周围循环灌注不足的表现，以及两者不同程度的合并存在。
作者 钟灵
机构地区 南宁茅桥中心医院内科
出处 《中国基层医药》 CAS 2011年第23期3289-3290,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 慢性心力衰竭 左心室舒张末压 临床综合征 治疗 心肌收缩功能 心排血量 灌注不足 周围循环
分类号 R541 [医药卫生—心血管疾病]
  • 相关文献

参考文献21

  • 1吴学思,李小鹰,许顶立,宁田海.全国世纪之交心力衰竭学术研讨会纪要[J].中华心血管病杂志,2002,30(1):2-6. 被引量：70
  • 2李仁祧,任宏生.心力衰竭的评估标准及常用检测方法[J].山东医药,2005,45(13):68-69. 被引量：23
  • 3黎云燕,康毅.慢性心力衰竭药物治疗的新进展[J].天津药学,2005,17(3):53-56. 被引量：2
  • 4张新超.心力衰竭治疗的若干进展[J].世界急危重病医学杂志,2005,2(4):822-827. 被引量：10
  • 5Salukhe TV ,Francis DP, Sutton R. Comparison of medical therapy,pacing and defibrillation in heart failure (COMPANION) trail terminated early: combined biventricular pacemaker-defibrillators reduce all-cause mortality and hospilalization. Int J Cardio1,2003, 87(2) :119-120.
  • 6Young JB, Abraham WT, Smith AL,et al. Combined cardiac resynchronization and implantable cardio version defibrillator in advanced chronic heart failure: the MIRACLEICD trial. JAMA, 2003,289 ( 20 ) : 2685-2694.
  • 7Neuhold S, Hue lsmann M, Strunk G,et al. Comparison of copeptin, B-type natriuret ic peptid, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure:prediction of death at different stages of the disease. J Am Coll Cardliol, 2008,52(4) :266-272.
  • 8刘桂芹,劳金龙,邱美英.慢性心力衰竭药物治疗研究进展[J].中国煤炭工业医学杂志,2005,8(9):934-935. 被引量：6
  • 9高明政,袁凤娟.慢性收缩性心力衰竭的临床用药[J].中国误诊学杂志,2005,5(18):3577-3579. 被引量：4
  • 10Mills RM, LeJemtel TH, Horton DP. Sustained hemody-namic effects of an infusion of nesiritide( human b-type natriuret-ic peptide) in heart failure : a randomized, doubleblind, placebo-controlled clinical trial. Natrecor Study Group, J Am Coil Cardiol, 1999,34( 1 ) : 155-162.

二级参考文献28

  • 1Francis G S, Goldsmith S R, Levine T B, et al. The neurohumorial axis in congestive heart failure. Ann Interm Med, 1984, 101 (3):370.
  • 2The CONSENSUS Tiial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Surival Study (CONSENSUS) . N Engl J Med,1987,316:1249.
  • 3Francis G S. Comparison of neuroendocirne activity in patients with left ventricular dysfunction with or without congestive heart failure(SOLVD) . Circulation,1990,82.. 1724.
  • 4Vantrimpont P, Rouleau J L, Wun C, et al . For the SAVE Inves-tigatiuon. Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the survival and ventricular enlargement(SAVE) study. J Am Coll Cardiol,1997,29:229.
  • 5Witherow F N, Heimy A, Webb D J. et al. Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure. Circulation, 2001,104 (18) : 2177.
  • 6Cohn J N, Tognomi G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Mcd,2001,345 : 1667.
  • 7Pit B, Poole-Wilaom PA, Segal R, et al. Effects of losartan compared with eaptopril on mortality in patients with symptomatic heart failure: randomized trial-the Losartan Heart Failure Surival Study ELITE Ⅱ.Lancet,2000,355:15827.
  • 8Zannad F, Alla F, Dousset B, et al. Limination of excessive extracellular matrix turnover may contribute to survival benefit of pirondactone therapy in patients with congestive heart failure. Circulation, 2000,102 (22) : 2700.
  • 9Eichhom E, Domanski M, Krause-Steirrauf H A. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med,2001,344(22) : 1659.
  • 10Seed A, Love MP, McMurray J J. Clinical experience with endothelin receptor antagonists in chronic heart failure. Heart Failure Rev,2003,6(4) :317.

共引文献105

同被引文献55

引证文献6

二级引证文献48

中国基层医药
2011年 第23期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部